Pentoxifylline partially reverts the effect of tumor necrosis factor on human islets.
Arias-Díaz
J
J
Department of Biochemistry, Facultad de Medicina, Universidad Complutense, Madrid, Spain.
Vara
E
E
García
C
C
Torres-Melero
J
J
Rodríguez
J M
JM
Balibrea
J L
JL
D000241:Adenosine; D000493:Allopurinol; D002478:Cells, Cultured; D046508:Culture Techniques / Q000379:methods; D005934:Glucagon / Q000378:metabolism*; D005947:Glucose / Q000494:pharmacology; D005978:Glutathione; D006801:Humans; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D007700:Kinetics; D019188:Organ Preservation Solutions; D010431:Pentoxifylline / Q000494:pharmacology*; D011887:Raffinose; D013004:Somatostatin / Q000378:metabolism; D013973:Thyrotropin-Releasing Hormone / Q000378:metabolism; D014019:Tissue Donors; D014021:Tissue Preservation; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000494:pharmacology*
D007328:Insulin; D019188:Organ Preservation Solutions; D014409:Tumor Necrosis Factor-alpha; C055206:University of Wisconsin-lactobionate solution; D013004:Somatostatin; D013973:Thyrotropin-Releasing Hormone; D000493:Allopurinol; D005934:Glucagon; D005978:Glutathione; D005947:Glucose; D000241:Adenosine; D011887:Raffinose; D010431:Pentoxifylline